{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T07:17:56Z","timestamp":1726211876410},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,16]]},"DOI":"10.7759\/cureus.15061","type":"journal-article","created":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T18:42:42Z","timestamp":1621190562000},"source":"Crossref","is-referenced-by-count":4,"title":["A Retrospective Review of Upper Gastrointestinal Bleed Outcomes During Hospital Admission While on Oral Anticoagulation"],"prefix":"10.7759","author":[{"given":"Nicolina","family":"Scibelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Mangano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Raynor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratishtha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.01.011","article-title":"2019 AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"74","author":"January CT","year":"2019","unstructured":"January CT, Wann LS, Calkins H, et al.. 2019 AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019, 74:104-32. 10.1016\/j.jacc.2019.01.011","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel MR","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, et al.. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011, 365:883-91. 10.1056\/NEJMoa1009638","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger CB","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, et al.. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011, 365:981-92. 10.1056\/NEJMoa1107039","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly SJ","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, et al.. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009, 361:1139-51. 10.1056\/NEJMoa0905561","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-563056","article-title":"Evolving use of new oral anticoagulants for treatment of venous thromboembolism","volume":"124","author":"Yeh CH","year":"2014","unstructured":"Yeh CH, Gross PL, Weitz JI. Evolving use of new oral anticoagulants for treatment of venous thromboembolism. Blood. 2014, 124:1020-8. 10.1182\/blood-2014-03-563056","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"Schulman S","year":"2009","unstructured":"Schulman S, Kearon C, Kakkar AK, et al.. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med. 2009, 361:2342-52. 10.1056\/NEJMoa0906598","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano RP","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E, et al.. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013, 369:2093-104. 10.1056\/NEJMoa1310907","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff CT","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, et al.. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014, 383:955-62. 10.1016\/S0140-6736(13)62343-0","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144856","article-title":"Comparison of the novel oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in the initial and long-term treatment and prevention of venous thromboembolism: systematic review and network meta-analysis","volume":"10","author":"Cohen AT","year":"2015","unstructured":"Cohen AT, Hamilton M, Mitchell SA, et al.. Comparison of the novel oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in the initial and long-term treatment and prevention of venous thromboembolism: systematic review and network meta-analysis. PLoS One. 2015, 10:e0144856. 10.1371\/journal.pone.0144856","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2017.11.007","article-title":"Severity of gastrointestinal bleeding in patients treated with direct-acting oral anticoagulants","volume":"131","author":"Brodie MM","year":"2018","unstructured":"Brodie MM, Newman JC, Smith T, Rockey DC. Severity of gastrointestinal bleeding in patients treated with direct-acting oral anticoagulants. Am J Med. 2018, 131:573.e9-573.e15. 10.1016\/j.amjmed.2017.11.007","journal-title":"Am J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.17242","article-title":"Association of oral anticoagulants and proton pump inhibitor cotherapy with hospitalization for upper gastrointestinal tract bleeding","volume":"320","author":"Ray WA","year":"2018","unstructured":"Ray WA, Chung CP, Murray KT, Smalley WE, Daugherty JR, Dupont WD, Stein CM. Association of oral anticoagulants and proton pump inhibitor cotherapy with hospitalization for upper gastrointestinal tract bleeding. JAMA. 2018, 320:2221-30. 10.1001\/jama.2018.17242","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1046\/j.0306-5251.2001.01220.x","article-title":"Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark","volume":"53","author":"Mellemkjaer L","year":"2002","unstructured":"Mellemkjaer L, Blot WJ, S\u00f8rensen HT, Thomassen L, McLaughlin JK, Nielsen GL, Olsen JH. Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark. Br J Clin Pharmacol. 2002, 53:173-81. 10.1046\/j.0306-5251.2001.01220.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-015-3806-6","article-title":"Alcohol abuse increases rebleeding risk and mortality in patients with non-variceal upper gastrointestinal bleeding","volume":"60","author":"K\u00e4rkk\u00e4inen JM","year":"2015","unstructured":"K\u00e4rkk\u00e4inen JM, Miilunpohja S, Rantanen T, Koskela JM, Jyrkk\u00e4 J, Hartikainen J, Paajanen H. Alcohol abuse increases rebleeding risk and mortality in patients with non-variceal upper gastrointestinal bleeding. Dig Dis Sci. 2015, 60:3707-15. 10.1007\/s10620-015-3806-6","journal-title":"Dig Dis Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09260913","article-title":"Upper gastrointestinal bleeding in patients with CKD","volume":"9","author":"Liang CC","year":"2014","unstructured":"Liang CC, Wang SM, Kuo HL, et al.. Upper gastrointestinal bleeding in patients with CKD. Clin J Am Soc Nephrol. 2014, 9:1354-9. 10.2215\/CJN.09260913","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/59151-a-retrospective-review-of-upper-gastrointestinal-bleed-outcomes-during-hospital-admission-while-on-oral-anticoagulation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:28:51Z","timestamp":1707506931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/59151-a-retrospective-review-of-upper-gastrointestinal-bleed-outcomes-during-hospital-admission-while-on-oral-anticoagulation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,16]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.15061","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,16]]}}}